01 1Zhejiang Raybow Pharma
01 1ERIBULIN MESYLATE
01 1U.S.A
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2022-10-20
Pay. Date : 2022-09-28
DMF Number : 37388
Submission : 2022-09-02
Status : Active
Type : II
20
Zhejiang Raybow Pharmaceutical Co Ltd, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ERIBULIN MESYLATE, with a corresponding US DMF Number 37388.
Remarkably, this DMF maintains an Active status since its submission on September 02, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 20, 2022, and payment made on September 28, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II
